Verition Fund Management
DCPH

Verition Fund Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Verition Fund Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,160
Closed -$218K – 2763
2023
Q3 		$218K Sell
17,160
-1,080
-6% -$14.9K ﹤0.01% 1930
2023
Q2 		$257K Buy
+18,240
New +$261K ﹤0.01% 1677
2020
Q1 		– Sell
-12,241
Closed -$762K – 1133
2019
Q4 		$762K Sell
12,241
-3,133
-20% -$149K 0.01% 526
2019
Q3 		$522K Buy
+15,374
New +$455K 0.01% 610

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Verition Fund Management's DCPH Position: Q4 2023 in Review

Verition Fund Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2023, closing a stake of 17,160 shares — an estimated $218K sold.

Verition Fund Management first reported a position in DCPH in Q3 2019 and held it in 4 quarters. The position peaked at $762K in Q4 2019. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.

  • Verition Fund Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 17,160 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $218K.
  • Verition Fund Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Verition Fund Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $762K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.